Abstract
Objective
Nailfold capillaroscopy (NC) is a non-invasive tool that can detect microvascular changes in the early stages of vascular disease. To assess capillary microarchitecture in children with type 1 diabetes mellitus (T1DM) and its relationship with clinical characteristics, laboratory findings, and glycemic control.
Methods
We included children and adolescents with T1DM, aged 6-18 years, and diagnosed for at least one year and an equal number of age- and sex-matched healthy controls. For all patients with T1DM, data on diabetes duration were collected, and the average annual HbA1c value was calculated for the four measurements made at routine follow-up in the preceeding year. In patients using 24-hour continuous glucose monitoring (CGM) devices, glycemic data from the previous three months were analyzed. The capillaroscopic findings were evaluated by two different researchers with experience in the field of pediatric rheumatology. Capillaroscopic parameters were compared based on glycemic control (HbA1c ≥7.5% vs. <7.5%), disease duration (<5 vs. ≥5 years), time in range (TIR≥70% vs. <70%), and glucose variability (CV≤36% vs. >36%).
Results
The median age of the 55 patients with T1DM was 14.5 (11.3-17.2) years, with a median disease duration of 3.8 (2.3-6.7) years. Compared to controls, patients with T1DM had significantly lower capillary density and more frequent dilated, tortuous, cross-linked, and abnormal capillaries (p<0.001, p<0.001, p<0.001, p=0.01, and p=0.03, respectively). Capillary density was significantly lower in patients with poor glycemic control (p<0.001) and those with longer disease duration (p=0.02). A negative correlation was observed between capillary density and disease duration (r=-0.3, p=0.02). After adjusting for age, gender, body mass index, and diabetes duration, capillary density remained negatively correlated with average HbA1c (r=-0.4, p=0.004). Among CGM users (n=22), capillary density showed a positive correlation with TIR (r=0.5, p=0.04), even after adjustment for confounders.
Conclusion
Children with T1DM exhibited significantly higher microvascular changes, mostly associated with poor glycemic control, compared to healthy controls. NC may be a useful technique for detecting early alterations in the capillary structures of children with T1DM, even in the absence of overt clinical microvascular complications.
Keywords: Diabetic vasculopathy, morbidity, hyperglycemia, insulin, screening
Read the full text
5 sections · 2 figures · 4 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus - a comprehensive review. J Diabetes Complications. 2020;34:107613. Epub 2020 May 4
Shestakova MV, Jarek-Martynowa IR, Ivanishina NS, Kuharenko SS, Yadrihinskaya MN, Aleksandrov AA, Dedov II. Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2005;68(Suppl 1):65-72.
Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS, Wadwa RP, Zabeen B, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1432-1450.
Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:17016.
Hosking SP, Bhatia R, Crock PA, Wright I, Squance ML, Reeves G. Non-invasive detection of microvascular changes in a paediatric and adolescent population with type 1 diabetes: a pilot cross-sectional study. BMC Endocr Disord. 2013;13:41.
Bogusz-Górna K, Polańska A, Dańczak-Pazdrowska A, Żaba R, Sumińska M, Fichna P, Kędzia A. Non-invasive detection of early microvascular changes in juveniles with type 1 diabetes. Cardiovasc Diabetol. 2023;22:285.
Korkmaz HA, Devebacak A, Erbaş İM, Değirmenci C, Uyar N, Afrashi F, Özkan B. Comparison of optical coherence tomography angiography findings between healthy children and children with type 1 diabetes mellitus and autoimmune thyroiditis. J Clin Res Pediatr Endocrinol. 2023;15:390-396. Epub 2023 Jul 20
Sorelli M, Francia P, Bocchi L, De Bellis A, Anichini R. Assessment of cutaneous microcirculation by laser Doppler flowmetry in type 1 diabetes. Microvasc Res. 2019;124:91-96. Epub 2019 Apr 6
Zharkikh E, Dremin V, Zherebtsov E, Dunaev A, Meglinski I. Biophotonics methods for functional monitoring of complications of diabetes mellitus. J Biophotonics. 2020;13:e202000203. Epub 2020 Aug 1
Goh JK, Cheung CY, Sim SS, Tan PC, Tan GS, Wong TY. Retinal imaging techniques for diabetic retinopathy screening. J Diabetes Sci Technol. 2016;10:282-294.
Parati G, Bilo G. Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care. 2009;32(Suppl 2):298-304.
Gallucci F, Russo R, Buono R, Acampora R, Madrid E, Uomo G. Indications and results of videocapillaroscopy in clinical practice. Adv Med Sci. 2008;53:149-157.
Kaminska-Winciorek G, Deja G, Polańska J, Jarosz-Chobot P. Diabetic microangiopathy in capillaroscopic examination of juveniles with diabetes type 1. Postepy Hig Med Dosw (Online). 2012;66:51-59.
Abdelmaksoud AA, Daifallah SM, Salah NY, Saber AS. Nail fold microangiopathy in adolescents with type 1 diabetes: relation to diabetic vascular complications. Microcirculation. 2022;29:e12771. Epub 2022 Jun 12
Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY, Jefferies CA, Oram RA, Dabelea D, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23:1160-1174.
Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F, Baş F. Reference values for weight, height, head circumference, and body mass ındex in Turkish children. J Clin Res Pediatr Endocrinol. 2015;7:280-293.
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11:42-57. Epub 2022 Dec 6. Erratum in: Lancet Diabetes Endocrinol. 2024;12:e12.
Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Müller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19:102458. Epub 2020 Jan 10
Sullivan GM, Feinn R. Using effect size-or why the p value is not enough. J Grad Med Educ. 2012;4:279-282.
Barchetta I, Riccieri V, Vasile M, Stefanantoni K, Comberiati P, Taverniti L, Cavallo MG. High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy. Diabet Med. 2011;28:1039-1044.
Meyer MF, Pfohl M, Schatz H. Nachweis diabetischer Mikrozirkulationsveränderungen mittels Kapillaroskopie und Laser-Doppler-Anemometrie [Assessment of diabetic alterations of microcirculation by means of capillaroscopy and laser-Doppler anemometry]. Med Klin (Munich). 2001;96:71-77. [in German]
Maldonado G, Paredes C, Roberto G, Ríos C. Nailfold capillaroscopy a non-invasive tool for direct observation of microvascular damage in diabetes mellitus: review. JSM Atheroscler. 2017;2:1037.
Ríos Acosta CR, Maldonado Vélez GC, Ferro Gutiérrez CA, Ríos Moreno K. Estudio de patrones capilaroscópicos en población sana. Rev Arg Reumatol. 2016;27:27-31.
Hoerth C, Kundi M, Katzenschlager R, Hirschl M. Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa. 2012;41:19-26.
Dundar HA, Adrovic A, Demir S, Demir F, Cakmak F, Ayaz NA, Sözeri B, Bilginer Y, Kasapçopur O, Unsal E. Description of the characteristics of the nailfold capillary structure in healthy children: a multi-centric study. Rheumatology (Oxford). 2024;63: SI152-SI159.
Er E, Ata A, Evin F, Altınok YA, Demir G, Özen S, Darcan Ş, Gökşen D. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2020;33:1533-1537.
Huang L, Pan Y, Zhou K, Liu H, Zhong S. Correlation between glycemic variability and diabetic complications: a narrative review. Int J Gen Med. 2023;16:3083-3094.
Benitez-Aguirre P, Craig ME, Cass HG, Sugden CJ, Jenkins AJ, Wang JJ, Cusumano J, Hodgson LA, Lee K, Wong TY, Donaghue KC. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Invest Ophthalmol Vis Sci. 2014;56:571-577.
Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN, Dunger DB. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ. 2008;336:697-701. Epub 2008 Mar 18
Vurallı D, Jalilova L, Alikaşifoğlu A, Özön ZA, Gönç EN, Kandemir N. Cardiovascular risk factors in adolescents with type 1 diabetes: prevalence and gender differences. J Clin Res Pediatr Endocrinol. 2024;16:11-20. Epub 2023 Aug 10
Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care. 2003;26:1224-1229.
Cho YH, Craig ME, Donaghue KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15:18-26. Epub 2014 Jan 20
Donaghue KC, Craig ME, Chan AK, Fairchild JM, Cusumano JM, Verge CF, Crock PA, Hing SJ, Howard NJ, Silink M. Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes. Diabet Med. 2005;22:711-718.
Rajaei A, Dehghan P, Farahani Z. Nailfold capillaroscopy findings in diabetic patients (a pilot cross-sectional study). Open J Pathol. 2015;5:65-72.
Kuryliszyn-Moskal A, Dubicki A, Zarzycki W, Zonnenberg A, Górska M. Microvascular abnormalities in capillaroscopy correlate with higher serum IL-18 and sE-selectin levels in patients with type 1 diabetes complicated by microangiopathy. Folia Histochem Cytobiol. 2011;49:104-110.
Yilmaz U, Ayan A, Uyar S, Inci A, Ozer H, Yilmaz FT, Demirtas G, Kok M, Tokuc A. Capillaroscopic appearance of nailfold vasculature of diabetic nephropathy patients. Arch Endocrinol Metab. 2022;66:295-302. Epub 2022 May 12
Maldonado G, Guerrero R, Paredes C, Ríos C. Nailfold capillaroscopy in diabetes mellitus. Microvasc Res. 2017;112:41-46. Epub 2017 Mar 6
Hsu PC, Liao PY, Chang HH, Chiang JY, Huang YC, Lo LC. Nailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy. Medicine (Baltimore). 2016;95:e5714.
Lisco G, Triggiani V. Computerized nailfold video-capillaroscopy in type 2 diabetes: a cross-sectional study on 102 outpatients. J Diabetes. 2023;15:890-899. Epub 2023 Jul 9
Bakirci S, Celik E, Acikgoz SB, Erturk Z, Tocoglu AG, Imga NN, Kaya M, Tamer A. The evaluation of nailfold videocapillaroscopy findings in patients with type 2 diabetes with and without diabetic retinopathy. North Clin Istanb. 2018;6:146-150.
Chang CH, Tsai RK, Wu WC, Kuo SL, Yu HS. Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. Microvasc Res. 1997;53:121-127.


